Global Short Read Sequencing Market
Medical Equipment

Short Read Sequencing Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theShort Read Sequencing Market?

The increased occurrence of genetic disorders is anticipated to boost the expansion of the short-read sequencing market in the future. Genetic disorders involve abnormalities or mutations within an individual’s DNA or genes, resulting in physical, developmental, or biochemical irregularities that can adversely affect their health. Short-read sequencing is applied in genetic diseases to thoroughly scrutinize the genome and detect variants linked to the disease. For example, in June 2022, RARE-X, a patient assistance platform based in Australia, released a report stating that there were a total of 10,867 rare diseases, which included both genetic and non-genetic conditions. Consequently, the escalating occurrence of genetic disorders is stimulating the growth of the short-read sequencing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11912&type=smp

#What is the Projected CAGR for the Short Read Sequencing Market Size from 2025 to 2034?

The market size of short read sequencing has seen a significant boom in the recent past. The market which was valued at $6.66 billion in 2024, is projected to reach $7.86 billion in 2025, presenting a compound annual growth rate (CAGR) of 18.0%. The factors contributing to the robust growth during this period include advancements in genomic research, rise in genetic disorders incidence, growth in pharma and biotech research, utilization in diagnostics, and a decrease in the costs of sequencing.

Expectations are high for a swift expansion in the short read sequencing market in the coming years. By 2029, it’s projected to reach $15.21 billion, with a CAGR of 17.9%. This predicted growth during the forecast period is due to advancements in precision medicine, a significant increase in personalized genomics, the widening use in agriculture, the swell in microbiome research, and the escalating demand in developing markets. Notable forecast period trends include automation and high-throughput, solutions based on cloud technology, the incorporation of AI and machine learning, portable sequencing technologies, and the synergy of long-read sequencing.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11912

What Are the Current Market Growth and Trends in theShort Read Sequencing Market That Industry Players Should Watch?

The primary trend gaining traction in the short-read sequencing market is advancements in technology. Maintaining a competitive edge and enhancing observational capabilities are the objectives of main players in this market, with a focus on technological development. For instance, in October 2022, Pacific Biosciences Inc., a leading American manufacturer of superior, high precision sequencing technologies, introduced the Onso sequencing system for external beta testing. This system aims to deliver accurate data while also being cost-efficient. It was created specifically to deliver sensitive and specific targeted sequence analysis results for researchers in the field of oncology.

What Are the Major Market Players Making an Impact on theShort Read Sequencing Market Growth?

Major companies operating in the short read sequencing market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Cytiva Lifesciences, Eurofins Scientific SE, Agilent Technologies Inc., Beckman Coulter Inc., Illumina Inc., QIAGEN N.V., PerkinElmer Inc., BGI Genomics Co Ltd, MGI Tech Co. Ltd., GenScript Biotech Corporation., 10x Genomics Inc., Novogene Co. Ltd, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., Genewiz Inc., Zymo Research Corporation, GenapSys Inc., Fasteris SA, Paragon Genomics Inc., Nabsys Inc., GATC Biotech AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

How Are the Key Segments of the Short Read Sequencing Market Driving Opportunities and Innovations?

The short read sequencing market covered in this report is segmented –

1) By Product: Instruments, Consumables, Services.

2) By Technology: Next-Generation Sequencing, Sanger Sequencing.

3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis.

4) By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri genomics And Forensics, HLA Typing Or Immune System Monitoring.

5) By End Users: Academic Research, Hospitals And Clinics, Clinical Research, Pharmaceutical And Biotechnology Companies.

Subsegments:

1) By Instruments: Next-Generation Sequencing (NGS) Systems, Sequencing Platforms, Library Preparation Systems

2) By Consumables: Reagents And Kits, Flow Cells, Sample Preparation Consumables

3) By Services: Sequencing Services, Data Analysis Services, Bioinformatics Services

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11912&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theShort Read Sequencing Market?# Market Expansion?

North America was the largest region in the Short Read Sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Short Read Sequencing Maret 2025, By The Business Research Company:

Anti-Hypertensive Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Antisense & RNAi Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Alzheimer’s Disease Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: